Literature DB >> 1670865

Response to heparin in patients with ulcerative colitis.

P R Gaffney, J J O'Leary, C T Doyle, A Gaffney, J Hogan, F Smew, P Annis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1670865     DOI： 10.1016/0140-6736(91)92201-c

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Medical approaches and future options in chronic active ulcerative colitis.

Authors:  J T Siveke; C Folwaczny
Journal:  Int J Colorectal Dis       Date:  2004-01-15       Impact factor: 2.571

2.  Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy.

Authors:  R Day; M Ilyas; P Daszak; I Talbot; A Forbes
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease.

Authors:  M Noguchi; N Hiwatashi; Z Liu; T Toyota
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

4.  Lack of crucial role of mast cells in pathogenesis of experimental colitis in mice.

Authors:  A Minocha; C Thomas; R Omar
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

5.  Heparin Attenuates the Expression of TNFalpha-induced Cerebral Endothelial Cell Adhesion Molecule.

Authors:  Jeong Ho Lee; Chul Hoon Kim; Gi Ho Seo; Jinu Lee; Joo Hee Kim; Dong Goo Kim; Young Soo Ahn
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

6.  Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease.

Authors:  J C Souto; E Martínez; M Roca; J Mateo; J Pujol; D González; J Fontcuberta
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 7.  New developments in the pharmacotherapy of inflammatory bowel disease.

Authors:  J W Harting
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

8.  The microvascular thrombi of colonic tissue in ulcerative colitis.

Authors:  Guobin He; Qin Ouyang; Daiyun Chen; Fengyuan Li; Jingguo Zhou
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

9.  'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.

Authors:  A D Dwarakanath; L G Yu; C Brookes; D Pryce; J M Rhodes
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

10.  Heparin and related drugs: beyond anticoagulant activity.

Authors:  Clive Page
Journal:  ISRN Pharmacol       Date:  2013-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.